Literature DB >> 26299166

Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease.

Mohamad Alkhouli1, Paul Sandhu2, Khlaed Boobes3, Kamel Hatahet4, Farhan Raza5, Yousef Boobes6.   

Abstract

Cardiovascular disease is the leading cause of the death in dialysis patients. Arteriovenous fistulas (AVFs) are associated with lower mortality and are viewed as the desired access option in most patients with advanced kidney disease needing dialysis. However, AVFs have significant and potentially deleterious effects on cardiac functions particularly in the setting of preexisting heart disease. This article provides a comprehensive and contemporary review to what is known about the impact of AVFs on: congestive heart failure, left ventricular hypertrophy, pulmonary hypertension, right ventricular dysfunction, coronary artery disease and valvular heart disease.
Copyright © 2015 The Authors. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Acceso vascular para hemodiálisis; Cardiovascular; Fistula; Fístula; Hemodialysis vascular access; Kidney transplantation; Trasplante renal

Mesh:

Year:  2015        PMID: 26299166     DOI: 10.1016/j.nefro.2015.03.001

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  10 in total

1.  A Rare Case of Fatal Endocarditis and Sepsis Caused by Pseudomonas aeruginosa in a Patient with Chronic Renal Failure.

Authors:  Manav Aggarwal; Vikrant Vijan; Anjith Vupputuri; Sandya Nandakumar; Navin Mathew
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Use of a 4 mm Amplatzer Vascular Plug II in the treatment of a renal arteriovenous fistula: a case report.

Authors:  Davide Castellano; Andrea Boghi; Chiara Comelli; Luca Di Maggio; Daniele Savio
Journal:  CVIR Endovasc       Date:  2021-05-14

3.  Pulmonary hypertension and post-operative outcome in renal transplant: A retrospective analysis of 170 patients.

Authors:  Vipin Kumar Goyal; Sohan Lal Solanki; Birbal Baj
Journal:  Indian J Anaesth       Date:  2018-02

Review 4.  Effect of Nocturnal Hemodialysis versus Conventional Hemodialysis on End-Stage Renal Disease: A Meta-Analysis and Systematic Review.

Authors:  Fangjie Liu; Yiting Sun; Tianhua Xu; Li Sun; Linlin Liu; Wei Sun; Xin Feng; Jianfei Ma; Lining Wang; Li Yao
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

5.  Arteriovenous fistula after radial catheterization with cardiopulmonary repercussions.

Authors:  Alexandre Faraco de Oliveira; Alexandre David Ribeiro; Marcio Costa Silveira Ávila
Journal:  J Vasc Bras       Date:  2019-01-30

6.  Prehemodialysis arteriovenous access creation is associated with better cardiovascular outcomes in patients receiving hemodialysis: a population-based cohort study.

Authors:  Cheng-Chieh Yen; Mei-Yin Liu; Po-Wei Chen; Peir-Haur Hung; Tse-Hsuan Su; Yueh-Han Hsu
Journal:  PeerJ       Date:  2019-04-03       Impact factor: 2.984

7.  Are high flow arteriovenous accesses associated with worse haemodialysis?

Authors:  Ivo Laranjinha; Patrícia Matias; Ana Azevedo; David Navarro; Carina Ferreira; Tiago Amaral; Marco Mendes; Inês Aires; Cristina Jorge; Célia Gil; Anibal Ferreira
Journal:  J Bras Nefrol       Date:  2018-05-28

8.  NT-pro-BNP as marker for cardiac strain that may be caused by high-output arteriovenous shunting in a haemodialysis patient. A case report.

Authors:  Michaela Wärja; Emelie Laveborn; Michael Ott; Andreas P Jonsson; Bernd Stegmayr
Journal:  BMC Nephrol       Date:  2020-12-21       Impact factor: 2.388

Review 9.  Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.

Authors:  Mazen Al-Qadi; Barbara LeVarge; H James Ford
Journal:  Front Med (Lausanne)       Date:  2021-03-25

Review 10.  Arteriovenous access in hemodialysis: A multidisciplinary perspective for future solutions.

Authors:  Bernd Stegmayr; Christian Willems; Thomas Groth; Albino Martins; Nuno M Neves; Khosrow Mottaghy; Andrea Remuzzi; Beat Walpoth
Journal:  Int J Artif Organs       Date:  2020-05-22       Impact factor: 1.595

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.